Literature DB >> 26540383

A pathway to HIV-1 neutralization breadth.

S Abigail Smith1, Cynthia A Derdeyn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26540383      PMCID： PMC4769374          DOI： 10.1038/nm.3989

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter.

Authors:  Rebecca M Lynch; Rong Rong; Saikat Boliar; Anurag Sethi; Bing Li; Joseph Mulenga; Susan Allen; James E Robinson; S Gnanakaran; Cynthia A Derdeyn
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

2.  Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.

Authors:  Penny L Moore; Daniel Sheward; Molati Nonyane; Nthabeleng Ranchobe; Tandile Hermanus; Elin S Gray; Salim S Abdool Karim; Carolyn Williamson; Lynn Morris
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

3.  Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.

Authors:  Andrew T McGuire; Jolene A Glenn; Adriana Lippy; Leonidas Stamatatos
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 4.  Virological features associated with the development of broadly neutralizing antibodies to HIV-1.

Authors:  Penny L Moore; Carolyn Williamson; Lynn Morris
Journal:  Trends Microbiol       Date:  2015-01-05       Impact factor: 17.079

5.  Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

Authors:  Nicole A Doria-Rose; Chaim A Schramm; Jason Gorman; Penny L Moore; Jinal N Bhiman; Brandon J DeKosky; Michael J Ernandes; Ivelin S Georgiev; Helen J Kim; Marie Pancera; Ryan P Staupe; Han R Altae-Tran; Robert T Bailer; Ema T Crooks; Albert Cupo; Aliaksandr Druz; Nigel J Garrett; Kam H Hoi; Rui Kong; Mark K Louder; Nancy S Longo; Krisha McKee; Molati Nonyane; Sijy O'Dell; Ryan S Roark; Rebecca S Rudicell; Stephen D Schmidt; Daniel J Sheward; Cinque Soto; Constantinos Kurt Wibmer; Yongping Yang; Zhenhai Zhang; James C Mullikin; James M Binley; Rogier W Sanders; Ian A Wilson; John P Moore; Andrew B Ward; George Georgiou; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris; Peter D Kwong; Lawrence Shapiro; John R Mascola
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962

6.  Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape.

Authors:  Penny L Moore; Elin S Gray; C Kurt Wibmer; Jinal N Bhiman; Molati Nonyane; Daniel J Sheward; Tandile Hermanus; Shringkhala Bajimaya; Nancy L Tumba; Melissa-Rose Abrahams; Bronwen E Lambson; Nthabeleng Ranchobe; Lihua Ping; Nobubelo Ngandu; Quarraisha Abdool Karim; Salim S Abdool Karim; Ronald I Swanstrom; Michael S Seaman; Carolyn Williamson; Lynn Morris
Journal:  Nat Med       Date:  2012-10-21       Impact factor: 53.440

Review 7.  Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection.

Authors:  Cynthia A Derdeyn; Penny L Moore; Lynn Morris
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

8.  Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.

Authors:  Constantinos Kurt Wibmer; Jinal N Bhiman; Elin S Gray; Nancy Tumba; Salim S Abdool Karim; Carolyn Williamson; Lynn Morris; Penny L Moore
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

9.  Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.

Authors:  Hua-Xin Liao; Rebecca Lynch; Tongqing Zhou; Feng Gao; S Munir Alam; Scott D Boyd; Andrew Z Fire; Krishna M Roskin; Chaim A Schramm; Zhenhai Zhang; Jiang Zhu; Lawrence Shapiro; James C Mullikin; S Gnanakaran; Peter Hraber; Kevin Wiehe; Garnett Kelsoe; Guang Yang; Shi-Mao Xia; David C Montefiori; Robert Parks; Krissey E Lloyd; Richard M Scearce; Kelly A Soderberg; Myron Cohen; Gift Kamanga; Mark K Louder; Lillian M Tran; Yue Chen; Fangping Cai; Sheri Chen; Stephanie Moquin; Xiulian Du; M Gordon Joyce; Sanjay Srivatsan; Baoshan Zhang; Anqi Zheng; George M Shaw; Beatrice H Hahn; Thomas B Kepler; Bette T M Korber; Peter D Kwong; John R Mascola; Barton F Haynes
Journal:  Nature       Date:  2013-04-03       Impact factor: 49.962

10.  Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.

Authors:  Megan K Murphy; Ling Yue; Ruimin Pan; Saikat Boliar; Anurag Sethi; Jianhui Tian; Katja Pfafferot; Etienne Karita; Susan A Allen; Emmanuel Cormier; Paul A Goepfert; Persephone Borrow; James E Robinson; S Gnanakaran; Eric Hunter; Xiang-Peng Kong; Cynthia A Derdeyn
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823
View more
  1 in total

1.  Reduced frequency of HIV superinfection in a high-risk cohort in Zambia.

Authors:  Evonne Woodson; Debby Basu; Hope Olszewski; Jill Gilmour; Ilene Brill; William Kilembe; Susan Allen; Eric Hunter
Journal:  Virology       Date:  2019-06-15       Impact factor: 3.616
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.